Cost-effectiveness of nonsteroidal anti-inflammatory drugs and opioids in the treatment of knee osteoarthritis in older patients with multiple comorbidities
- 1 March 2016
- journal article
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 24 (3) , 409-418
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trialsThe Lancet, 2013
- American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and kneeArthritis Care & Research, 2012
- Opioid Analgesics and the Risk of Fractures in Older Adults with ArthritisJournal of the American Geriatrics Society, 2011
- Forecasting the burden of advanced knee osteoarthritis over a 10-year period in a cohort of 60–64 year-old US adultsOsteoarthritis and Cartilage, 2011
- Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID useBMC Gastroenterology, 2009
- Comorbidity, limitations in activities and pain in patients with osteoarthritis of the hip or kneeBMC Musculoskeletal Disorders, 2008
- Cutpoints for mild, moderate and severe pain in patients with osteoarthritis of the hip or knee ready for joint replacement surgeryBMC Musculoskeletal Disorders, 2008
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part IIArthritis & Rheumatism, 2007
- Acetaminophen for osteoarthritisCochrane Database of Systematic Reviews, 2006
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000